Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 840Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1BRISTOL M.SQUIBB PHARMA EEIG

02 1BRISTOL-MYERS SQUIBB Srl

03 2Bristol Myers Squibb Pharma EEIG

04 3Bristol-Myers Squibb Pharma Eeig

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Daclatasvir 30Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 30 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Daclatasvir 60Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 60 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 30 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 60 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Daclatasvir Dihydrochloride

Brand Name : Daklinza

Dosage Form : Film Coated Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 22/08/2014

Application Number : 20131204000054

Regulatory Info : Deregistered

Registration Country : Sweden

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Daclatasvir Dihydrochloride

Brand Name : Daklinza

Dosage Form : Film Coated Tablet

Dosage Strength : 60mg

Packaging :

Approval Date : 22/08/2014

Application Number : 20131204000061

Regulatory Info : Deregistered

Registration Country : Sweden

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Daclatasvir Dihydrochloride

Brand Name : Daklinza

Dosage Form : Film Coated Tablet

Dosage Strength : 90mg

Packaging :

Approval Date : 24/06/2016

Application Number : 20151209000095

Regulatory Info : Deregistered

Registration Country : Sweden

blank